Lucas Motta Martinez, Lorena Cristina São Leão Ribeiro, Rodrigo Gilles Guidi, Caio Mazzonetto Teofilo de Moraes, Catharina Ribeiro Lyra, Bruno Liebl, Vinicius Henrique Almeida Guimarães, Richard Dobrucki de Lima, Lucas Schenk de Almeida, Caio Vinicius Suartz, William Carlos Nahas, Leopoldo Alves Ribeiro-Filho
{"title":"Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder.","authors":"Lucas Motta Martinez, Lorena Cristina São Leão Ribeiro, Rodrigo Gilles Guidi, Caio Mazzonetto Teofilo de Moraes, Catharina Ribeiro Lyra, Bruno Liebl, Vinicius Henrique Almeida Guimarães, Richard Dobrucki de Lima, Lucas Schenk de Almeida, Caio Vinicius Suartz, William Carlos Nahas, Leopoldo Alves Ribeiro-Filho","doi":"10.1007/s11912-025-01648-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>This narrative review aims to discuss the latest evidence for cell-free tumor DNA (ctDNA) use in bladder cancer, future perspectives and challenges in implementing this technology in clinical practice.</p><p><strong>Recent findings: </strong>Recent papers describe promising findings regarding ctDNA analysis in blood samples and in urine of bladder cancer patients. This biomarker can be used as a diagnostic tool, in prognostic evaluation and as additional data for treatment indication and surveillance.</p>","PeriodicalId":10861,"journal":{"name":"Current Oncology Reports","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Oncology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11912-025-01648-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of review: This narrative review aims to discuss the latest evidence for cell-free tumor DNA (ctDNA) use in bladder cancer, future perspectives and challenges in implementing this technology in clinical practice.
Recent findings: Recent papers describe promising findings regarding ctDNA analysis in blood samples and in urine of bladder cancer patients. This biomarker can be used as a diagnostic tool, in prognostic evaluation and as additional data for treatment indication and surveillance.
期刊介绍：
This journal aims to review the most important, recently published clinical findings in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer.
We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
